Mental Health, Retinal Disease Linked: Study Shows Higher Risk Table of Contents Mental Health, Retinal Disease Linked: Study Shows Higher Risk mental health link: bipolar, depression tied to higher risk of retinal disease, vision loss the connection between mental health and vision key findings at a glance did you know? study methodology the numbers behind … Read more
TOPLINE: Individuals older than 50 years with bipolar or major depressive disorder were more likely to have retinal disease, and those with a diagnosis of retinal disease and a psychiatric illness were at sharply higher risk for impaired vision than those with retinal disease alone. METHODOLOGY: Researchers conducted a retrospective cohort analysis of adults aged … Read more
Chinese scientists use AI to help visually impaired to ‘see’, explore the world South China Morning Post Human-centred design and fabrication of a wearable multimodal visual assistance system Nature Wearable AI system helps blind people navigate Tech Xplore Source link
As we age, our cognitive abilities deteriorate – it becomes increasingly difficult to remember, orient ourselves in time and space, and solve problems. However, good hearing and vision positively impact cognitive abilities in older adults. This is shown in Andreea Badache’s doctoral thesis in disability science at örebro University. By ensuring good hearing … Read more
Using real-world data from over 300,000 cases, scientists uncovered a significant link between semaglutide and reported vision problems—raising new concerns about the safety profile of this blockbuster medication. Study: Increased vision impairment reports linked to semaglutide: analysis of FDA adverse event data. Image Credit: memorisz / Shutterstock A team of researchers at the University of Bern, Switzerland, … Read more
Since July 2024, faricimab has also been approved in Europe for the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion. The German Institute for Quality and Efficiency in Health Care (IQWiG) has now examined in an early benefit assessment whether faricimab offers patients benefits over ranibizumab or aflibercept. However, the … Read more
Faricimab Treatment for Macular Oedema: IQWiG Finds Lack of Added Benefit The German Institute for Quality and Efficiency in Health Care (IQWiG) has recently assessed the benefits of faricimab for treating visual impairment caused by macular oedema secondary to retinal vein occlusion. This follows its approval in Europe in July 2024. However, the evaluation concluded … Read more
Since July 2024, faricimab has also been approved in Europe for the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion. The German Institute for Quality and Efficiency in Health Care (IQWiG) has now examined in an early benefit assessment whether faricimab offers patients benefits over ranibizumab or aflibercept. However, the … Read more